期刊文献+

体外培养脑胶质瘤细胞株中CD133表达的研究 被引量:6

Expression of CD133 in in vitro cultured glioma cells
原文传递
导出
摘要 目的探讨与脑胶质瘤干细胞相关的CD133表型。方法将无血清培养中的胶质瘤干细胞与含血清贴壁培养的胶质瘤细胞中CD133的表达进行对比。逆转录.聚合酶链反应(RT-PCR)及实时荧光定量PCR检测信使RNA(mRNA)水平的表达,流式细胞术及免疫荧光染色法检测蛋白水平的表达,激光共聚焦扫描成像进行CDl33蛋白的亚细胞定位。结果所有胶质瘤细胞中均存在CD133mRNA及蛋白的表达。AC133抗体所识别的糖基化CD133-AC133分子仅分布于无血清培养中的胶质瘤干细胞,阳性细胞比例为31.8%~99.9%,且定位于此类细胞膜表面。AC133阴性的胶质瘤干细胞及含血清贴壁培养胶质瘤细胞中CD133蛋白的表达位于细胞内,阳性细胞比例约为22.2%~88.6%,其亚细胞定位为内质网和/或高尔基体。结论细胞表面AC133分子,而非CD133mRNA及细胞内CD133蛋白标记了一类胶质瘤干细胞亚群,但无血清培养环境下也存在AC133呈阴性表达的胶质瘤干细胞亚群。 Objective To discuss the CD133 phenotype correlating with glioma stem cells. Methods The expression of CD133 in glioma stem cell lines which were cultured in stem cell permissive serum-free medium was compared with that in conventional adherent glioma cell lines which were established in serum-containing medium. Reverse transcription-polymerase chain reaction (RT-PCR) and real-time quan-titative PCR were performed to study the expression level of CD133 mRNA. Flow cytometry and immunoflu-orescent staining were done to study the protein expression. Con_focal microscopy was adopted to study the subcellular localization of CD133 protein. Results CD133 mRNA and protein were distributed both in glioma stem cells and conventional adherent glioma cell lines. The glycosylated CD133-AC133 detected by AC133 antibody was only found in glioma stem cells cultured in serum-free medium and located on the cell membrane, and the proportion of positive cells was 31.8%-99. 9%. The CD133 protein in the AC133 neg-ative glioma stem cells and conventional adherent glioma cell lines was found intracellularly and located in the endoplasmic reticulum and/or Golgi apparatus, and the proportion of positive cells was 22. 2%- 88. 6%. Conclusion Neither CD133 mRNA nor intracellular CD133 protein but AC133 phenotype on the cell membrane is closely correlated with glioma stem cells, but a group of AC133 negative glioma stem cells can also exist in serum-free medium.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第4期678-681,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30801177、30901749)
关键词 CD133 AC133 胶质瘤 脑肿瘤干细胞 CD133 AC133 Glioma Brain tumor stem cell
  • 相关文献

参考文献10

  • 1Neuzil J, Stantic M, Zobalova R, et al. Tumour-initiating cells vs. cancer 'stem' cells and CD133 :what's in the name? Biochem Bio- phys Res Commun, 2007,355 : 855-859.
  • 2雷霆,万锋.进一步研究脑肿瘤干细胞调节机制及其应用[J].中华实验外科杂志,2010,27(10):1373-1374. 被引量:11
  • 3Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133 + and CD133- metastatie colon cancer cells initiate tumors. J Clin Invest, 2008, 118 : 2111 - 2120.
  • 4曹亮,胡祥,张怡.锁定并分离真正意义的肿瘤干细胞研究进展[J].中华实验外科杂志,2010,27(4):541-542. 被引量:2
  • 5Sgambato A, Puglisi MA, Errico F, et al. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells : Implications for its detection. J Cell Physiol, 201 O, 224 : 234 -241.
  • 6Florek M, Haase M, Marzesco AM, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker,is expressed in adult human dif- ferentiated cells and certain types of kidney cancer. Cell Tissue Res, 2005,319:15-26.
  • 7Campos B, Wan F, Farhadi M, et al. Differentiation therapy exerts an- titumor effects on stem-like glioma cells. C|in Cancer Res,2010,16: 2715-2728.
  • 8Griguer CE, Oliva CR, Gobin E, et al. CD133 is a marker of bioener- zetic stress in human z.lioma. PLoS One.2008.3 :e3655.
  • 9Lottaz C, Beier D, Meyer K, et al. Transcriptional profiles of CD133^+ and CD133 - glioblastoma-derived cancer stem cell lines suggest dif- ferent cells of origin. Cancer Res,2010,70:2030-2040.
  • 10Vagin O, Kraut JA, Sachs G. Role of N-glycosylation in trafficking of apical membrane proteins in epithelia. Am J Physiol Renal Physiol, 2009,296 : F459-469.

二级参考文献2

共引文献11

同被引文献53

  • 1洪涛,孙华,蒋丽萍,何安慰,卢明巍.全反式维甲酸诱导脑胶质瘤化疗的旁观者效应[J].中华实验外科杂志,2005,22(3):379-379. 被引量:6
  • 2綦斌,罗毅男,田宇.全反式维甲酸对脑胶质瘤细胞Cyclin E、Caspase-3表达的影响[J].中华实验外科杂志,2006,23(6):721-723. 被引量:7
  • 3PaolaGallinari,StefaniaDiMarco,PhillipJones,MichelePallaoro,ChristianSteinkühler.HDACs,histone deacetylation and gene transcription: from molecular biology to cancer therapeutics[J].Cell Research,2007,17(3):195-211. 被引量:36
  • 4Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents [J]. N Engl J Med, 2000, 343 (19): 1350-1354.
  • 5Egeblad M, Werb Z. New functions for the matrix metallo- proteinases in cancer progression [J]. Nat Rev Cancer, 2002, 2(3): 161-174.
  • 6Vanmeter TE, Rooprai HK, Kibble MM, et al. The role of matrix metalloproteinase genes in glioma invasion: co-de- pendent and interactive proteolysis [J]. J Neurooncol, 2001, 53(2): 213-235.
  • 7Tirino V, Desiderio V, D'Aquino R, et al. Detection and characterization of C D 133" cancer stem ceils in human solid tumours [J]. PLoS One, 2008, 3(10): e3469.
  • 8Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells [J]. Nature, 2009, 458(7239):780-783.
  • 9Haque A, Banik NL, Ray SK. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoi- mmunotherapy in the management of human glioblastoma [J]. Neurochem Res, 2007, 32(12): 2203-2209.
  • 10Niu CS, Li MW, Ni YF, et al. Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells [J]. J Exp Clin Cancer Res, 2010, 29:113.

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部